NCT05073926View on ClinicalTrials.gov

Rifampicin Resistance in S. Aureus During and After Treatment for Latent Tuberculosis

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

September 30, 2021

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Latent TuberculosisStaphylococcus Aureus
Interventions
OTHER

No intervention is part of the study protocol

No intervention is part of the study protocol. The choice of treatment for latent tuberculosis is is made by the treating physician.

Trial Locations (1)

20502

RECRUITING

Skåne University Hospital, Malmo

All Listed Sponsors
lead

Region Skane

OTHER